Patents by Inventor Phillipe Le Bouteiller

Phillipe Le Bouteiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2
    Publication number: 20140120110
    Abstract: The present invention relates to biological and medical applications of an anti-CD160 monoclonal antibody (CL1-R2 CNCM I-3204) and of the conservative equivalents thereof. It more particularly relates to the applications of these anti-CD160 compounds in the fields of EC angiogenesis, and NK and T cytokine production.
    Type: Application
    Filed: April 12, 2013
    Publication date: May 1, 2014
    Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Armand Bensussan, Laurence Boumsell, Phillipe Le Bouteiller
  • Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2
    Patent number: 8444978
    Abstract: The present invention relates to biological and medical applications of an anti-CD160 monoclonal antibody (CL1-R2 CNCM I-3204) and of the conservative equivalents thereof. It more particularly relates to the applications of these anti-CD160 compounds in the fields of EC angiogenesis, and NK and T cytokine production.
    Type: Grant
    Filed: July 1, 2011
    Date of Patent: May 21, 2013
    Assignee: INSERM (Institut National de la Santé et de la Recherche Médicale)
    Inventors: Armand Bensussan, Laurence Boumsell, Phillipe Le Bouteiller